Marinus Pharmaceuticals Inc

NASDAQ:MRNS   3:59:51 PM EDT
15.89
+1.25 (+8.54%)
Earnings Announcements

Marinus Pharmaceuticals Reports Qtrly Loss Per Share $0.51

Published: 11/09/2020 21:54 GMT
Marinus Pharmaceuticals Inc (MRNS) - Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2020 Financial Results.
Marinus Pharmaceuticals - Qtrly Loss per Share $0.51.
Marinus Pharmaceuticals Inc - at Sept 30, Had Cash, Equivalents & Investments of $91.3 Million Versus $91.7 Million at Dec 31, 2019.
Revenue is expected to be $1.2 Million
Adjusted EPS is expected to be -$0.52

Next Quarter Revenue Guidance is expected to be $2.44 Million
Next Quarter EPS Guidance is expected to be -$0.47

More details on our Analysts Page.